BOSTON SCIENTIFIC CORPORATION Deferred Income Tax Liabilities, Net
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Income Tax Liabilities, Net of $221.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-03
- 2026-06-30: Deferred Income Tax Liabilities, Net $221.00M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $219.00M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $220.00M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $242.00M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $221.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $219.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $220.00M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $242.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $226.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $158.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $155.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $138.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $132.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $132.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $134.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $91.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $135.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $210.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $144.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $278.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $265.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $261.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $310.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $274.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $115.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $336.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $330.00M 10-K · filed 2022-02-23 |
| 2019-12-31 | $595.00M 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |